DUOSPORE
LIVE

Serial Number

79363539

Owner

Raf Dybajlo

Attorney

Timothy C. Bradley

Filing Date

Dec 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DUOSPORE Trademark

Serial Number: 79363539 • Registration: 7445224

DUOSPORE is a trademark filed by Raf Dybajlo on December 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Raf Dybajlo

Lindekensveld 7

Entity Type: 01

Trademark Details

Filing Date

December 29, 2022

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Pharmaceutical and veterinary preparations for medical or dietetic purposes, namely, preparations for treating infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; pharmaceutical drugs for medical or dietetic purposes, namely for treating infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; homeopathic preparations for use in the treatment of infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; foodstuffs for medical purposes, namely, dietetic animal foodstuffs for medical purposes; dietetic foodstuffs for medical purposes, namely dietetic foods adapted for medical use; dietetic substances in the nature of confectionery substances adapted for medical purposes; food additives based on plant extracts for medical purposes; dietary food supplements for medical or dietetic purposes; dietary fiber for use as an ingredient for medical purposes; active pharmaceutical ingredients for medical purposes, namely drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; enzymes, sugars, vitamins, vitamin preparations, minerals and mineral preparations for medical purposes; vitamin tablets; vitamin drops; gummy vitamins; effervescent vitamin tablets; fortifying medicated beverages, namely, beverages with added vitamins for medical purposes; fortifying dietetic beverages, namely, dietetic beverages with added vitamins for medical purposes; medicinal herbs and medicinal herb-based drinks; food supplements; pharmaceutical agents affecting metabolism; health food supplements for persons with special dietary requirements; pharmaceutical preparations for the prevention of diseases; nutraceuticals for use as a dietary supplement; infant formula; medical plasters; gauze materials for dressing; teeth filling material and dental wax; disinfectants; preparations for destroying noxious animals; fungicides and herbicides; sanitary preparations for medical use; dietetic substances adapted for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 26, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 26, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2024 COAR
REFUSAL PROCESSED BY IB
Nov 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 30, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 29, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2023 REPR